Tin tức & Cập nhật
Xem bài viết Gan
Xem
Chỉ hiển thị Multimedia

Bile acid reductions with odevixibat tied to improved LFTs in patients with PFIC2
16 Jul 2026
bởiAudrey Abella
In individuals receiving odevixibat for progressive familial intrahepatic cholestasis 2 (PFIC2), also known as bile salt export pump (BSEP) deficiency, reductions in serum bile acid (sBA) levels correlated with improvements in key liver function tests (LFTs), according to a post hoc subgroup analysis presented at ESPGHAN 2026.
Bile acid reductions with odevixibat tied to improved LFTs in patients with PFIC2
16 Jul 2026
Direct-acting antivirals improve survival in patients with HCV-related HCC
22 Jun 2026
bởiStephen Padilla
A recent study in UK has shown a significant proportion of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) initiating direct-acting antiviral (DAA) therapy, resulting in improvements in sustained virological response (SVR) rates.







